Yesterday | BioSpace
Cephalon, Inc. Ending Provigil Promotion Deal with Takeda Pharmaceutical Co. Ltd.
Cephalon, Inc. Ending Provigil Promotion Deal with Takeda Pharmaceutical Co. Ltd. 9/5/2008 Cephalon Inc.
Cephalon ends pact for Provigil
Cephalon Inc. of East Whiteland will end its co-promotion agreement with Takeda Pharmaceuticals North America Inc.
Cephalon ending Provigil promotion deal with Takeda
Cephalon Inc. has provided written notice to Takeda Pharmaceuticals North America Inc.
SL Pharma Wins SFDA Approval for New Drug and a Clinical Trial
Beijing SL Pharmaceutical Co. Ltd. received SFDA approval to begin producing a hepatitis drug and a second SFDA authorization to begin clinical trials of drug for male infertility.
King's $1.2 billion bid for Alpharma, announced last Friday, is a leveraged bet on pain drugs, particularly new abuse-resistant opioid therapies.
Tired All the Time? It May be Sleep Apnea
Repetitive blockages of the airway, called obstructive sleep apnea , can reduce airflow or cause breathing to stop.
Five Cash Flow Kings For August 18
A company's net income and earnings per share can provide insight into its well being and progress over time.
Alcohol Dependence Drug Can Cause Adverse Reactions Warned FDA
Main Category: Regulatory Affairs / Drug Approvals Also Included In: Alcohol / Addiction / Illegal Drugs Article Date: 13 Aug 2008 The US Food and Drug Administration issued an alert to healthcare professionals ...
FDA: skin reactions with alcoholism drug 5:29PM ET
Federal regulators warned doctors Tuesday about severe skin reactions seen in patients taking an injectable treatment for alcoholism made by Alkermes Inc.
FDA warns about Alkermes-Cephalon alcoholism drug
A drug to treat alcoholism developed by Alkermes Inc. has caused blood clots, swelling, abscesses, cell death and other adverse reactions in nearly 200 cases, according to a warning for health-care ...
FDA On Pace To Approve 18 New Drugs In 2008
The U.S. Food and Drug Administration has approved nine new medicines as of the end of June, putting it on pace to be one of the slowest years for new drug approvals in the last five years.
A Drug Stock With a Promising Pipeline
JOLTED AWAKE EARLIER THIS YEAR after a dismal 2007, narcolepsy drug maker Cephalon resembles something out of a pleasant dream.
A drug to treat alcholism, commercialized mainly by Cephalon Inc. in the U.S., received marketing approval in Russia.
Five Stocks That Are Defying Market Conditions
Although it seems that every day we are hit with negative data points on the economy, it's not all bad news out there.
PowerRatings Weekly Outlook: KMB, KFT, DIS, CEPH, TMX
Topsy Turvy is a good term to describe the action this week. Dramatic and often counteracting economic news combined with radical swings in companies earning compared to estimates, tossed the market up and then ...
Top PowerRatings Upgrades for Investors: BKH, CEPH, TMX
Today, stocks in the utility sector dominate the upper end of the Long Term Power Rating upgrades.
Cephalon, Inc. Q2 2008 Earnings Call
Cephalon, Inc. Q2 FY08 Earnings Call July 29, 2008, 05:00 PM ET Executives Robert Merritt - IR Frank Baldino, Jr., Ph.D. - Chairman and CEO Robert P. Roche, Jr.
Cephalon, Inc. Q2 2008 Earnings Call
Cephalon, Inc. Q2 FY08 Earnings Call July 29, 2008, 05:00 PM ET Executives Robert Merritt - IR Frank Baldino, Jr., Ph.D. - Chairman and CEO Robert P. Roche, Jr.
Cephalon, Inc. Q2 2008 Earnings Call
Cephalon, Inc. Q2 FY08 Earnings Call July 29, 2008, 05:00 PM ET Executives Robert Merritt - IR Frank Baldino, Jr., Ph.D. - Chairman and CEO Robert P. Roche, Jr.
Cephalon Swings To Second-quarter Profit
You know that buying a stock makes you part owner of a company, theoretically with millions of other people.
Read more articles in the Cephalon News Archives.
For up to the minute news, check out the Cephalon News Wire.
Want to add Cephalon News headlines to your web site? Get the widget here.
Comment?
Talk about Cephalon
Do you have something to say about Cephalon? 
Cephalon Poll
Top Stories
Most Popular
News Trends
